Issued Patents All Time
Showing 1–25 of 40 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12023384 | Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif | Vincent Carlier, Luc Vander Elst, David Burkhart | 2024-07-02 |
| 11787849 | Methods and compounds for eliminating immune responses to therapeutic agents | Luc Vander Elst, Vincent Carlier | 2023-10-17 |
| 11760782 | Peptides and methods for the treatment of diabetes | Luc Vander Elst, Vincent Carlier | 2023-09-19 |
| 11718650 | Immunogenic peptides and their use in immune disorders | — | 2023-08-08 |
| 11407795 | Peptides and methods for the treatment of diabetes | Luc Vander Elst, Vincent Carlier | 2022-08-09 |
| 11236127 | Modulation of antigen immunogenicity by addition of epitopes recognized by NKT cells | — | 2022-02-01 |
| 11226332 | Method for the detection, preparation and depletion of CD4+ t lymphocytes | Vincent Carlier, Luc Vander Elst | 2022-01-18 |
| 11193114 | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination | — | 2021-12-07 |
| 11091512 | Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells | — | 2021-08-17 |
| 10982196 | Immunotherapy targeting intracellular pathogens | — | 2021-04-20 |
| 10899795 | Modified epitopes for boosting CD4+ T-cell responses | — | 2021-01-26 |
| 10808016 | Peptides and methods for the treatment of diabetes | Luc Vander Elst, Vincent Carlier | 2020-10-20 |
| 10729791 | Animal models for evaluating pharmaceutical compounds | Luc Vander Elst, Vincent Carlier | 2020-08-04 |
| 10662232 | Immunogenic peptides and their use in immune disorders | — | 2020-05-26 |
| 10617748 | Immunogenic control of tumours and tumour cells | — | 2020-04-14 |
| 10087233 | Coagulation factor VIII with reduced immunogenicity | — | 2018-10-02 |
| 10023847 | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination | — | 2018-07-17 |
| 9861661 | Elimination of immune responses to viral vectors | — | 2018-01-09 |
| 9732118 | Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells | — | 2017-08-15 |
| 9394517 | CD4+ T-cells with cytolytic properties | — | 2016-07-19 |
| 9249202 | Immunogenic peptides and their use in immune disorders | — | 2016-02-02 |
| 9248171 | Immunogenic peptides and their use in transplantation | — | 2016-02-02 |
| 9044507 | Elimination of immune responses to viral vectors | — | 2015-06-02 |
| 8999346 | Immunogenic control of tumours and tumour cells | — | 2015-04-07 |
| 8784816 | Antibodies which bind factor VIII | Marc Jacquemin | 2014-07-22 |